Renalytix Announces Holding Change
Why we think this is neutral
This RNS announcement does not contain any of the mandatory news types, such as contract news, order news, trading update, financing, funding, annual results, asset sale/disposal, flow testing, licence news, or delisting. Therefore, the sentiment is assessed as neutral.
Key Points
- UBS Group AG - Investment Bank & Global Wealth Management now holds 5.34% of the voting rights in Renalytix PLC
- The change in shareholding was reported on 24 June 2025 and notified to the company on 26 June 2025
Summary
The healthcare company has announced a change in shareholding, with UBS Group AG - Investment Bank & Global Wealth Management now holding 5.34% of the voting rights.
Renalytix PLC has announced that UBS Group AG - Investment Bank & Global Wealth Management now holds 5.34% of the voting rights in the company. This change in shareholding was reported on 24 June 2025 and notified to the company on 26 June 2025.
DIRECTOR DEALINGS